Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9622598 | 1.00 | TSHR (0.50) | TSHRCYP3A4MAPTMEN1THRB | |
| SCHEMBL29320743 | 0.97 | TSHR (0.48) | TSHRCYP3A4MAPTMEN1THRB | |
| SCHEMBL10498249 | 0.97 | TSHR (0.48) | TSHRCYP3A4MAPTMEN1THRB | |
| SCHEMBL10498292 | 0.97 | TSHR (0.48) | TSHRCYP3A4MAPTMEN1THRB | |
| SCHEMBL29320747 | 0.97 | TSHR (0.48) | TSHRCYP3A4MAPTMEN1THRB | |
| SCHEMBL23945735 | 0.97 | TSHR (0.48) | TSHRCYP3A4MAPTMEN1THRB | |
| SCHEMBL1150476 | 0.92 | HTT (0.48) | TSHRMAPTMEN1THRBHTT | |
| Pentane SCHEMBL3714433 | 0.92 | TSHR (0.40) | TSHRCYP3A4MAPTMEN1THRB | |
| Ethylene Glycol SCHEMBL10498287 | 0.91 | TSHR (0.60) | TSHRCYP3A4MAPTMEN1THRB | |
| SCHEMBL23854124 | 0.90 | HTT (0.52) | TSHRMAPTMEN1THRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4074739-A1 | TREATMENT LIQUID AND PATTERN FORMING METHOD | FUJIFILM Corporation (JP) | 2022-10-19 | — | — | EP | claimed |
| US-20220308449-A1 | TREATMENT LIQUID AND PATTERN FORMING METHOD | FUJIFILM CORPORATION (JP) | 2022-09-29 | — | — | US | claimed |
| CN-114787717-A | Processing liquid and pattern forming method | 富士胶片株式会社 | 2022-07-22 | — | — | CN | claimed |
| WO-2021117456-A1 | TREATMENT LIQUID AND PATTERN FORMING METHOD | 富士フイルム株式会社 | 2021-06-17 | — | — | WO | claimed |
| EP-0068799-A2 | Titanium trichloride catalyst component and the process for the production thereof | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-01-05 | — | — | EP | claimed |
| US-20240238458-A1 | COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF | PURDUE RESEARCH FOUNDATION | 2024-07-18 | — | — | US | disclosed |
| EP-3604983-B1 | METHOD FOR DETECTING LOCATION OF REFRIGERANT LEAK | DAIKIN IND LTD (JP) | 2024-07-17 | — | — | EP | disclosed |
| US-20240226343-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. | 2024-07-11 | — | — | US | disclosed |
| CN-117924548-A | Catalyst component for olefin polymerization, preparation method, catalyst system and olefin polymerization method | 中国石油化工股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| US-20230357158-A1 | QUINOLINE cGAS ANTAGONIST COMPOUNDS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2023-11-09 | — | — | US | disclosed |
| WO-2023171326-A1 | METHOD FOR PRODUCING ALKENE | 株式会社クレハ | 2023-09-14 | — | — | WO | disclosed |
| EP-0021822-A1 | Titanium trichloride catalytic component and method for homo- or co-polymerization of alpha-olefins | TOYO STAUFFER CHEMICAL CO. LTD. (JP) | 1981-01-07 | — | — | EP | disclosed |
| US-4240928-A | FOR POLYMERIZATION OF ALPHA-OLEFINS | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1980-12-23 | — | — | US | disclosed |
| US-4235745-A | FOR PREPARING HIGHLY STEREOSPECIFIC POLYMERS | TOYO STAUFFER CHEMICAL CO., LTD. (JP) | 1980-11-25 | — | — | US | disclosed |
| EP-0011914-A1 | Titanium trichloride catalyst composition and its use in the polymerization of alpha-olefins | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1980-06-11 | — | — | EP | disclosed |
| US-4200717-A | Preparation of propylene polymer-containing solid titanium trichloride and propylene polymers using same | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) | 1980-04-29 | — | — | US | disclosed |
| US-4115533-A | REDUCING TITANIUM TETRACHLORIDE WITH AN ORGANIC ALUMINUM COMPOUND | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) | 1978-09-19 | — | — | US | disclosed |
| US-4115532-A | LEWIS ACIDS, HEATING, PRECIPITATION | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) | 1978-09-19 | — | — | US | disclosed |
| US-4060593-A | Preparation of titanium trichloride | MITSUBISHI CHEMICAL INDUSTRIES (JA) | 1977-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873291-B2 | Quinoline cGAS antagonist compounds | CGAS, GLS2, GLS | TSHR 2355/4885CYP3A4 1291/4885MAPT 3235/4885 |
| US-20240238458-A1 | COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF | FAP, FIBP, FGFR1 | TSHR 4225/4885CYP3A4 4676/4885MAPT 3208/4885 |
| US-20230357158-A1 | QUINOLINE cGAS ANTAGONIST COMPOUNDS | CGAS, GLS2, GLS | TSHR 2355/4885CYP3A4 1291/4885MAPT 3235/4885 |
| US-20240226343-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | NPY1R, NPY2R, NPY4R | TSHR 76/4885CYP3A4 4773/4885MAPT 2444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.